How Vaccine Platforms Can Prepare Us for Future Pandemics
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
15/02/2021 - 6 minutes
Infectious disease
Universal Flu Vaccines Yield Second Clinical Failure This Year
In a blow to hopes for better protection from seasonal flu, last week’s phase III…
29/10/2020 - 5 minutes
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
06/07/2020 - 7 minutes
CureVac Bids to Develop First mRNA Coronavirus Vaccine
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global…
03/02/2020 - 2 minutes
Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…
09/01/2020 - 3 minutes
Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
03/01/2020 - 2 minutes
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
Danish Smallpox Vaccine Gets FDA Approval to Fight Bioterrorism
A vaccine developed by the Danish company Bavarian Nordic has received FDA approval to prevent…
25/09/2019 - 2 minutes
Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase…
18/09/2019 - 3 minutes
Sepsis Diagnosed in 5 Minutes Instead of 24 Hours with Swiss Biotech’s Test
A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict…
16/09/2019 - 3 minutes
Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
20/08/2019 - 3 minutes
First Potential Chlamydia Vaccine Shows Early Promise
A vaccine targeting the sexually transmitted infection chlamydia, which would be the first of its…
16/08/2019 - 3 minutes
